Temasek Holdings’s Eli Lilly LLY Stock Holding History

Temasek Holdings’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,300	Closed	-$20.8M	–	150
2025 Q3	$20.8M	Buy	+27,300	New	+$20.3M	0.07%	96

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Temasek Holdings's LLY Position: Q2 2026 in Review

Temasek Holdings reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $22.3M and leaving 151,473 shares worth $182M. The position accounts for 0.49% of the portfolio, ranked #38.

Temasek Holdings first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Temasek Holdings held 151,473 shares of Eli Lilly worth $182M as of Q2 2026.
Temasek Holdings sold 21,786 Eli Lilly shares in Q2 2026, an estimated $22.3M.
Eli Lilly made up 0.49% of Temasek Holdings's portfolio in Q2 2026, its #38 holding.
Temasek Holdings first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Temasek Holdings's 13F filing for Q2 2026, filed 7 Aug 2026.